Evoq Remedies Cash Flow Annual

BSE: 543500 | NSE: - | ISIN: INE0JVD01011 | Sector: Biotechnology & Drugs
4.41 -0.08 (-1.78%)Updated : 18 Jul 2025
Fiscal Period2025202420232022
Period End DateMar 25Mar 24Mar 23Mar 22
Issuance( Retirement)of Debt Net -4.24-5.341.428.16
Net Changein Cash 0.09-0.03-2.943.06
Cash Taxes Paid 0.040.160.670.37
Net Income/ Starting Line 0.130.612.281.46
Changesin Working Capital -14.804.70-6.64-27.89
Cashfrom Operating Activities -14.625.32-4.35-26.43
Cash Interest Paid 0.000.000.000.00
Cashfrom Financing Activities 14.97-5.341.4229.49
Issuance( Retirement)of Stock Net 19.210.000.0021.33
Depreciation/ Depletion 0.050.010.000.00
Other Investing Cash Flow Items Total 0.00-0.000.00
Capital Expenditures -0.26-0.01-0.010.00
period Type ----
Financing Cash Flow Items 0.000.000.000.00
period Length 12.0012.0012.0012.00
Cashfrom Investing Activities -0.26-0.01-0.010.00
Non- Cash Items --0.000.00
Deferred Taxes --0.000.00
*All figures in crores except per share values
Recommended For You
Trending Stocks
266.90+6.65(2.56%)
941.85+17.95(1.94%)
162.50+2.65(1.66%)
1,099.10-60.75 (-5.24%)
1,901.05-28.85 (-1.49%)